0 Commentarios
0 Acciones
609 Views
0 Vista previa
Buscar
Descubre nuevas personas, crear nuevas conexiones y hacer nuevos amigos
- Please log in to like, share and comment!
- Data Analytics in Duchenne Muscular Dystrophy Market for Revenue EnhancementAccording to the most recent analysis by Emergen Research, the market for duchenne muscular dystrophy in the world reached $1.03 billion in 2021 and is projected to grow at a rate of 40.7% over the forecast period. The prevalence of duchenne muscular dystrophy is rising, and there are more clinical trials and studies being conducted in the area of duchenne muscular dystrophy-based treatments,...0 Commentarios 0 Acciones 1320 Views 0 Vista previa
- Duchenne Muscular Dystrophy (DMD) Treatment Market Trends and Segments Forecast To 2029The global duchenne muscular dystrophy (dmd) treatment market size was valued at USD 3.8 billion in 2022 and is poised to grow at a significant CAGR of 38.2% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029. The research report includes historical data, trending features, and market growth...0 Commentarios 0 Acciones 1148 Views 0 Vista previa
- Duchenne Muscular Dystrophy Cure: Current Progress and Future ProspectsDuchenne Muscular Dystrophy Cure: Current Progress and Future Prospects Is the Cure for Duchenne Muscular Dystrophy in the Pipeline? Duchenne Muscular Dystrophy (DMD) is a severe and progressive neuromuscular disorder primarily affecting boys. It is caused by mutations in the dystrophin gene, leading to muscle degeneration and weakness. For decades, families and medical professionals have...0 Commentarios 0 Acciones 261 Views 0 Vista previa
- Duchenne Muscular Dystrophy Market Dynamics: Drivers, Challenges, and Future OutlookDuchenne Muscular Dystrophy Market Dynamics: Drivers, Challenges, and Future Outlook Duchenne Muscular Dystrophy Market: Trends, Opportunities, and Future Outlook Duchenne Muscular Dystrophy (DMD) is a severe genetic disorder characterized by progressive muscle degeneration and weakness. As the global healthcare landscape evolves, the Duchenne Muscular Dystrophy market is undergoing significant...0 Commentarios 0 Acciones 259 Views 0 Vista previa
- Duchenne Muscular Dystrophy Treatment Market Estimated to Witness High GrowthThe global Duchenne muscular dystrophy treatment market is estimated to be valued at US$ 2 billion in 2024 and is expected to exhibit a CAGR of 47% over the forecast period 2024-2028.Key TakeawaysKey players operating in the Duchenne muscular dystrophy treatment are Sarepta Therapeutics, Pfizer, PTC Therapeutics, Summit Therapeutics, and others. Sarepta Therapeutics' Exondys 51 was the first...0 Commentarios 0 Acciones 47 Views 0 Vista previa
- Global Duchenne Muscular Dystrophy Treatment Market Is Estimated To Witness High Growth Owing To Pfizer Inc. and Fibrogen Inc.The global Duchenne Muscular Dystrophy (DMD) Treatment Market is estimated to be valued at US$2,787.6 million in 2022 and is expected to exhibit a CAGR of 47.85% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.A) Market Overview:Duchenne Muscular Dystrophy is a rare genetic disorder that primarily affects males, leading to progressive...0 Commentarios 0 Acciones 1360 Views 0 Vista previa
- Uncovering New Horizons: Curative Treatments for Duchenne Muscular DystrophyIn Search for a Curative Treatment Option for Duchenne Muscular Dystrophy Duchenne Muscular Dystrophy (DMD) is a severe and progressive genetic disorder characterized by the rapid degeneration of muscle tissue. As one of the most common types of muscular dystrophy, DMD predominantly affects young boys, leading to significant muscle weakness and loss over time. With no definitive cure...0 Commentarios 0 Acciones 248 Views 0 Vista previa
- Understanding Corticosteroid Therapy in Duchenne Muscular Dystrophy (DMD) TreatmentCorticosteroid therapy is a cornerstone of Duchenne Muscular Dystrophy (DMD) treatment. These medications, such as prednisone and deflazacort, have shown significant benefits in slowing disease progression and prolonging ambulation in individuals with DMD. Corticosteroids work by reducing inflammation and suppressing muscle fiber damage, thus preserving muscle strength and function. However,...0 Commentarios 0 Acciones 1553 Views 0 Vista previa
- What’s Next in the Duchenne Muscular Dystrophy Market After Exon-Skipping Therapies?What’s Next in the Duchenne Muscular Dystrophy Market After Exon-Skipping Therapies? Duchenne Muscular Dystrophy Market: What’s More Beyond Exon-Skipping Therapies? Duchenne Muscular Dystrophy (DMD) is a severe genetic disorder characterized by progressive muscle degeneration and weakness. It primarily affects boys, and the lack of dystrophin, a protein crucial for muscle function,...0 Commentarios 0 Acciones 259 Views 0 Vista previa
- A New Hope for DMD: Sarepta’s ELEVIDYS Gene TherapySarepta’s ELEVIDYS: First Gene Therapy for Duchenne Muscular Dystrophy (DMD) Treatment Duchenne muscular dystrophy (DMD) is a devastating genetic disorder that primarily affects boys, leading to progressive muscle degeneration and weakness. Historically, DMD has been managed through supportive care, steroids, and emerging pharmaceutical therapies, but there has been no cure. The...0 Commentarios 0 Acciones 249 Views 0 Vista previa
- Breakthroughs in Alzheimer’s Disease Research: What’s on the Horizon?What Does the Future Hold For Gene Therapy in the Duchenne Muscular Dystrophy (DMD) Treatment Market? Duchenne muscular dystrophy (DMD) is a severe, X-linked genetic disorder characterized by progressive muscle degeneration and weakness. Affecting approximately 1 in 3,500 to 5,000 males globally, DMD is caused by mutations in the dystrophin gene, leading to the absence of dystrophin...0 Commentarios 0 Acciones 257 Views 0 Vista previa
- Sternal Wound Infection Market Dynamics and Forecast Insights - 2032Sternal Wound Infection Market Dynamics and Forecast Insights - 2032 Sternal Wound Infection: Market Insight, Epidemiology, and Market Forecast - 2032 Introduction Sternal wound infection (SWI) is a significant complication following sternotomy, commonly performed in cardiac surgeries. These infections can lead to extended hospital stays, increased healthcare costs, and higher mortality rates....0 Commentarios 0 Acciones 255 Views 0 Vista previa
Resultados de la búsqueda